fda compounded semaglutide news is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before FDA alerts health care providers,
Description
GLP-1 drugs like Ozempic and Wegovy may affect your sense of taste and the way your brain responds to sweet foods.

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults

It has been studied in human clinical trials and shown to support metabolic balance, healthy blood glucose regulation, inflammation management, and improved insulin function

These shakes provide an essential balance of nutrients while supporting critical weight loss

This guide explains how semaglutide functions in thyroidectomy patients and what you need to know about GLP-1 therapy when living without a thyroid
